Setting

Asia Pacific Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity

Published: 28 Sep 2020 | Report Code: 10247712 | Pages: 113

Asia Pacific pharmaceutical continuous manufacturing market will grow by 12.8% annually with a total addressable market cap of $5,299.8 million over 2020-2030 owing to the rising need for continuous manufacturing process due to cost saving and improved productivity. Highlighted with 32 tables and 42 figures, this 113-page report “Asia Pacific Pharmaceutical Continuous Manufacturing Market 2020-2030 by Product (Integrated, Semi-Continuous, Controls & Software), Application (End Product, API), End User, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific pharmaceutical continuous manufacturing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific pharmaceutical continuous manufacturing market in every aspect of the classification from perspectives of Product, Application, End User, and Country. Based on Product, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Integrated Continuous Systems Semi-Continuous Systems • Continuous Granulators • Continuous Blenders • Continuous Compressors • Continuous Coaters • Continuous Dryers • Other Semi-Continuous Systems Controls & Software Based on Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. End Product Manufacturing • Solid Dosage Manufacturing • Liquid Dosage Manufacturing API Manufacturing Based on End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Pharmaceutical Companies • Contract Manufacturing Organizations • Research Organizations and Institutes • Other End Users Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) Detailed analysis and 2019-2030 annual revenue are available for each key national market. The breakdown of key national markets by Product, Technology, and End User over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific pharmaceutical continuous manufacturing market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): ACG Group Alexanderwerk Baker Perkins Ltd. Coperion GmbH Fette Compacting Freund-vector Corporation GEA Group AG Gebrüder Lödige Maschinenbau GmbH Gericke AG Glatt GmbH Hosokawa Micron Corporation Korsch AG Leistritz AG Munson Machinery Company, Inc. Powrex Corp Scott Equipment Company Sturtevant, Inc. Thermo Fisher Scientific Inc. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	7
1.1 Industry Definition and Research Scope	7
1.1.1 Industry Definition	7
1.1.2 Research Scope	8
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	14
1.2.6 Market Size/Share Estimation	15
1.2.7 Research Limitations	16
1.3 Executive Summary	17
2 Market Overview and Dynamics	19
2.1 Market Size and Forecast	19
2.1.1 Impact of COVID-19 on World Economy	20
2.1.2 Impact of COVID-19 on the Market	23
2.2 Major Growth Drivers	25
2.3 Market Restraints and Challenges	28
2.4 Emerging Opportunities and Market Trends	31
2.5 Porter’s Fiver Forces Analysis	35
3 Segmentation of Asia Pacific Market by Product	41
3.1 Market Overview by Product	41
3.2 Integrated Continuous Systems	43
3.3 Semi-Continuous Systems	44
3.3.1 Continuous Granulators	46
3.3.2 Continuous Blenders	47
3.3.3 Continuous Compressors	48
3.3.4 Continuous Coaters	49
3.3.5 Continuous Dryers	50
3.3.6 Other Semi-Continuous Systems	51
3.4 Controls & Software	52
4 Segmentation of Asia Pacific Market by Application	53
4.1 Market Overview by Application	53
4.2 End Product Manufacturing	55
4.2.1 Solid Dosage Manufacturing	57
4.2.2 Liquid Dosage Manufacturing	58
4.3 API Manufacturing	59
5 Segmentation of Asia Pacific Market by End User	61
5.1 Market Overview by End User	61
5.2 Pharmaceutical Companies	63
5.3 Contract Manufacturing Organizations	64
5.4 Research Organizations and Institutes	65
5.5 Other End Users	66
6 Asia-Pacific Market 2019-2030 by Country	67
6.1 Overview of Asia-Pacific Market	67
6.2 Japan	70
6.3 China	73
6.4 Australia	76
6.5 India	78
6.6 South Korea	80
6.7 Rest of APAC Region	82
7 Competitive Landscape	84
7.1 Overview of Key Vendors	84
7.2 New Product Launch, Partnership, Investment, and M&A	87
7.3 Company Profiles	88
ACG Group	88
Alexanderwerk	90
Baker Perkins Ltd.	91
Coperion GmbH	92
Fette Compacting	93
Freund-vector Corporation	94
GEA Group AG	95
Gebrüder Lödige Maschinenbau GmbH	96
Gericke AG	97
Glatt GmbH	98
Hosokawa Micron Corporation	99
Korsch AG	100
Leistritz AG	101
Munson Machinery Company, Inc.	102
Powrex Corp	103
Scott Equipment Company	104
Sturtevant, Inc.	105
Thermo Fisher Scientific Inc.	106
8 Investing in Asia Pacific Market: Risk Assessment and Management	107
8.1 Risk Evaluation of Asia Pacific Market	107
8.2 Critical Success Factors (CSFs)	110
Related Reports and Products	113
List Of Tables

Table 1.  Snapshot of Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030	18
Table 2. Growth Rate of World Real GDP, 2017-2021	21
Table 3.  Main Product Trends and Market Opportunities in Asia Pacific Pharmaceutical Continuous Manufacturing Market	31
Table 4. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	41
Table 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems by Type, 2019-2030, $ mn	45
Table 6. Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	53
Table 7. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing by Type, 2019-2030, $ mn	56
Table 8. Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	61
Table 9. APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019-2030, $ mn	68
Table 10. Japan Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	72
Table 11. Japan Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	72
Table 12. Japan Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	72
Table 13. China Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	75
Table 14. China Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	75
Table 15. China Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	75
Table 16. Australia Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	77
Table 17. Australia Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	77
Table 18. Australia Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	77
Table 19. India Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	79
Table 20. India Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	79
Table 21. India Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	79
Table 22. South Korea Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, $ mn	81
Table 23. South Korea Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, $ mn	81
Table 24. South Korea Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, $ mn	81
Table 25. Pharmaceutical Continuous Manufacturing Market in Rest of APAC by Country, 2019-2030, $ mn	83
Table 26. ACG Group: Company Snapshot	88
Table 27. ACG Group: Business Segmentation	88
Table 28. ACG Group: Product Portfolio	89
Table 29. ACG Group: Revenue, 2016-2018, $ mn	89
Table 30. ACG Group: Recent Developments	89
Table 31.  Risk Evaluation for Investing in Asia Pacific Market, 2019-2030	108
Table 32. Critical Success Factors and Key Takeaways	111
List Of Figures

Figure 1. Research Method Flow Chart	11
Figure 2. Breakdown of Primary Research	13
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation	15
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030	17
Figure 5. Asia Pacific Pharmaceutical Continuous Manufacturing Market, 2019-2030, $ mn	19
Figure 6. Impact of COVID-19 on Business	23
Figure 7. Primary Drivers and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market	25
Figure 8. Primary Restraints and Impact Factors of Asia Pacific Pharmaceutical Continuous Manufacturing Market	28
Figure 9. Investment Opportunity Analysis	32
Figure 10. Porter’s Fiver Forces Analysis of Asia Pacific Pharmaceutical Continuous Manufacturing Market	35
Figure 11. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Product, 2019-2030, % of Sales Revenue	41
Figure 12. Asia Pacific Addressable Market Cap in 2020-2030 by Product, Value ($ mn) and Share (%)	42
Figure 13. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Integrated Continuous Systems, 2019-2030, $ mn	43
Figure 14. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Semi-Continuous Systems, 2019-2030, $ mn	44
Figure 15. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Granulators, 2019-2030, $ mn	46
Figure 16. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Blenders, 2019-2030, $ mn	47
Figure 17. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Compressors, 2019-2030, $ mn	48
Figure 18. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Coaters, 2019-2030, $ mn	49
Figure 19. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Continuous Dryers, 2019-2030, $ mn	50
Figure 20. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other Semi-Continuous Systems, 2019-2030, $ mn	51
Figure 21. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Controls & Software, 2019-2030, $ mn	52
Figure 22. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by Application, 2019-2030, % of Sales Revenue	54
Figure 23. Asia Pacific Addressable Market Cap in 2020-2030 by Application, Value ($ mn) and Share (%)	54
Figure 24. Asia Pacific Pharmaceutical Continuous Manufacturing Market: End Product Manufacturing, 2019-2030, $ mn	55
Figure 25. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Solid Dosage Manufacturing, 2019-2030, $ mn	57
Figure 26. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Liquid Dosage Manufacturing, 2019-2030, $ mn	58
Figure 27. Asia Pacific Pharmaceutical Continuous Manufacturing Market: API Manufacturing, 2019-2030, $ mn	59
Figure 28. Breakdown of Asia Pacific Pharmaceutical Continuous Manufacturing Market by End User, 2019-2030, % of Revenue	62
Figure 29. Asia Pacific Addressable Market Cap in 2020-2030 by End User, Value ($ mn) and Share (%)	62
Figure 30. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Pharmaceutical Companies, 2019-2030, $ mn	63
Figure 31. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Contract Manufacturing Organizations, 2019-2030, $ mn	64
Figure 32. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Research Organizations and Institutes, 2019-2030, $ mn	65
Figure 33. Asia Pacific Pharmaceutical Continuous Manufacturing Market: Other End Users, 2019-2030, $ mn	66
Figure 34. Breakdown of APAC Pharmaceutical Continuous Manufacturing Market by Country, 2019 and 2030, % of Revenue	68
Figure 35. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%)	69
Figure 36.  Pharmaceutical Continuous Manufacturing Market in Japan, 2019-2030, $ mn	71
Figure 37.  Pharmaceutical Continuous Manufacturing Market in China, 2019-2030, $ mn	74
Figure 38.  Pharmaceutical Continuous Manufacturing Market in Australia, 2019-2030, $ mn	76
Figure 39.  Pharmaceutical Continuous Manufacturing Market in India, 2019-2030, $ mn	78
Figure 40.  Pharmaceutical Continuous Manufacturing Market in South Korea, 2019-2030, $ mn	80
Figure 41.  Pharmaceutical Continuous Manufacturing Market in Rest of APAC, 2019-2030, $ mn	82
Figure 42. Growth Stage of Asia Pacific Pharmaceutical Continuous Manufacturing Industry over the Forecast Period	84

Key Players (this may not be a complete list and extra companies can be added upon request): 
ACG Group	
Alexanderwerk	
Baker Perkins Ltd.	
Coperion GmbH	
Fette Compacting	
Freund-vector Corporation	
GEA Group AG	
Gebrüder Lödige Maschinenbau GmbH	
Gericke AG	
Glatt GmbH	
Hosokawa Micron Corporation	
Korsch AG	
Leistritz AG	
Munson Machinery Company, Inc.	
Powrex Corp	
Scott Equipment Company	
Sturtevant, Inc.	
Thermo Fisher Scientific Inc.